2022
DOI: 10.1007/s11033-022-08041-5
|View full text |Cite
|
Sign up to set email alerts
|

In vitro phenotypic effects of Lipoxin A4 on M1 and M2 polarized macrophages derived from THP-1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 41 publications
0
4
0
Order By: Relevance
“…properties. Previous studies have demonstrated the anti-inflammatory effect of LXA4 on various cell types, such as stem cells from the apical papilla [26] and macrophages [5].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…properties. Previous studies have demonstrated the anti-inflammatory effect of LXA4 on various cell types, such as stem cells from the apical papilla [26] and macrophages [5].…”
Section: Discussionmentioning
confidence: 99%
“…Among SPMs, lipoxin A4 (LXA4), derived from arachidonic acid, serves as an immune modulatory mediator with the capacity to attenuate monocytes recruitment and to induce a pro resolving M2 phenotype [5,6]. In light of these properties, numerous studies have evaluated the therapeutic potential of this molecule for conditions such as asthma, metabolic disease, arthritis, pain, diabetic wound healing, vascular conditions including peripheral artery disease and aortic aneurysm and periodontitis [1,[7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…LXA 4 has differential actions in M1 and M2 macrophages. LXA 4 reduces the gene expression of pro-inflammatory cytokines in M1 macrophages and increases the IL-10 mRNA expression in M2 macrophages derived from THP-1 cells ( 89 ). LXA 4 also induces M2 polarization in a model of osteoarthritis ( 90 ).…”
Section: Discussionmentioning
confidence: 99%
“…Among SPMs, lipoxin A4 (LXA4), derived from arachidonic acid, serves as an immune modulatory mediator with the capacity to attenuate monocytes recruitment and to induce a pro resolving M2 phenotype [5,6]. In light of these properties, numerous studies have evaluated the therapeutic potential of this molecule for conditions such as asthma, metabolic disease, arthritis, pain, diabetic wound healing, vascular conditions including peripheral artery disease and aortic aneurysm and periodontitis [1,[7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%